management of hematemesis
TRANSCRIPT
Management of Hematemesis
Budhi Setiawan
Management of Hematemesis
• Objectives
• Risk Assessment
• Resuscitation
• Endoscopy
• Arteriography
• Tagged Red Cell Scan
• Surgical Intervention
• Drug Therapy
Objectives
• Hemodynamic resuscitation
• Cessation of bleeding source
• Prevention of future recurrence
Modified Forrest Classification for Upper GI bleeding
Class Endoscopic findings Re-bleeding
rate (%)
1a Spurting arterial vessel 80 - 90
1b Oozing hemorrhage 10 - 30
2a Non-bleeding vessel 50 - 60
2b Adherent clot 25 - 35
2c Ulcer base with black
spot sign
0 - 8
3 Clean base 0 - 12
Ulcer Appearance and Prognosis
Appearance Prevalence % Re-bleed % Mortality %
Clean base 42 5 2
Flat spot 20 10 3
Clot 17 22 7
Visible vessel 17 43 11
Active bleeding 18 55 11
Rockall Risk Stratification Score
Variable 0 1 2 3
Age (yrs)
< 60 60-80 >80
Shock
SBP>100mmHg
HR<100 bpm
SPB>100mmHg
HR>100bpm
SPB<100mmHg
Co-morbidity
No major co-morbidity Heart failure
Ischemic heart
disease
Any co-morbidity
Renal Failure
Liver disease
Disseminated
malignancy
Diagnosis
Mallory-Weiss tear. No
lesion identified. No
SSH
Malignancy of upper
GIT
Major SRH
None/Clean base.
Dark spot sign on
ulcer base
Adherent clot. Visible
vessel (non bleeding).
Oozing bleeding,
spurting arterial vessel
Resuscitation
• First thing first: ABC
• Fluid and blood replacement
• Preferably two IVs (16 or 18 gauge)
• Isotonic crystalloid solution (RL solution)
• Whole blood, packed RBCs and fresh frozen plasma
Resucitation (Cont’d)
• Nil per os
• Use of supplemental oxygen may help increase blood oxygen saturation
• Urinary catheter: accurate urine volume assessment
• Central Venous Pressure line to monitor patient’s fluid volume status
– Cardiac disease patients
Endoscopy
• Primary tool for diagnosing source of bleeding
• Before performing, may need to lavage for clearer view
• NG tube placed and room-temperature water or saline used
• Esophageal Tamponade:
• Sengstaken–Blakemore tube
• Minnesota tube
• Linton–Nachlas tube
Endoscopy (Cont’d)
• Injection:– Adrenaline (1:10,000)
– Sclerosant (sodium morrhuate, sodium tetradecyl sulfate, and ethanolamine oleate)
– Alcohol
– Fibrin glue (a mixture of thrombin & fibrinogen)
• Ablation:– Heater probe
– Bipolar Coagulation (BICAP)
– Argon Plasma
• Mechanical devices:– Endoclips or banding (small elastic bands)
Angiography
• For patients with obscure, continuous UGIBs
• Intra-arterial vasopressin
• Embolization (glue, gelfoam, sclerosant, coil)
• Can detect bleeding rate > 0.5 mL/min
• CT Angiography (CTA) is faster, easier, and more sensitive at detecting active bleeding (Dx only)
Tagged Red Cell Scan
• Technetium 99m-labeled red blood cell scan
• Detection of bleeds that are much slower(0.1– 0.4 mL/min.)
• Recommended before angiography
• It lowers the risk of complications from angiography
Transjugular intrahepatic portosystemic shunt (TIPS)
• It creates a communication through the hepatic parenchyma between the hepatic and portal veins.
• Methods of treating the portal hypertension.
• Complications:
– Intraperitoneal hemorrhage, right-sided heart failure, decompensated liver failure, shunt dysfunction and hepatic encephalopathy.
Surgical Intervention
Drug Therapy• Proton Pump Inhibitor
– Irreversibly blocking the H+/K+ ATPase system of the gastric parietal cells.
– It reduces recurrent bleeding, hospital stay, bood transfusion.
– It has no effect on mortality.
– Omeprazole, Lansoprazole, Pantoprazole etc
• H2 Receptor Antagonist
– Histamine H2-receptor antagonists (H2 blockers).
– No significant improvement in outcomes.
– cimetidine, ranitidine, famotidine
Drug Therapy (Cont’d)• Vasopressin:Telipressin
– An analogue of the natural hormone argininevasopressin
– It stimulates vasopressin-1 receptors
– It may reduce relative risk in mortality
• Somatostatin:Octreotide– A synthetic somatostatin analogue
– Splanchnic vasoconstriction
• Recombinant human factor VIIa (rFVIIa)– If a coagulopathy has been detected
– No greater benefit compares to placebo
Drug Therapy (Cont’d)
• Antibiotics– Portal Hypertension
• Increase of infection risk
– H.Pylori Infection
• Omeprazole, amoxicillin, and clarithromycin
• Omeprazole, metronidazole, and amoxicillin/clarithromycin,
– Erythromycin
• To aid gastric motility and emptying
• Promotes evacuation of intragastric blood and improves endoscopic visualization
Drug Therapy (Cont’d)
• Beta Blocker (Propranolol or Nadolol)
– For portal hypertension pasient
– It may lower portal venous pressure
• Prostaglandin analogue (Misoprostol)
– When patients must be administered NSAIDs
• Tranexamic acid
– An antifibrinolytic agent
– It is not often used
– It could lead to venous thrombosis
THANK YOU